<DOC>
	<DOCNO>NCT00312975</DOCNO>
	<brief_summary>The purpose trial study long patient remain progression free receive CP-675,206 , compare long patient remain progression free receive best supportive care . If choose take part , randomize receive either CP-675,206 maintenance therapy best supportive care . Best supportive care mean receive study drug treatment cancer . Best supportive care could include treatment antibiotic , analgesic drug ( medicine pain ) , blood transfusion psychosocial nutritional support , depend need . You 50 % chance randomize receive CP-675,206 .</brief_summary>
	<brief_title>Randomized Study Of CP-675,206 Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Tremelimumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Stage IIIb ( effusion ) stage IV disease respond remain stable 6 cycle platinum contain 1stline regimen Patients must able randomize 3 6 week last dose firstline therapy . No systemic therapy except 1stline platinum base treatment Symptomatic uncontrolled brain mets uncontrolled pleural effusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>